Literature DB >> 1542429

Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys.

B Gomez-Mancilla1, P J Bédard.   

Abstract

A group of 4 cynomolgus monkeys was rendered parkinsonian by the toxin MPTP and then treated daily with L-DOPA until all animals developed dyskinesia. At this point, 17 beta-estradiol, 17 alpha-estradiol and progesterone were injected s.c. singly or in combination for 7 days and the treatment with L-DOPA reinstituted. Our results show that the pretreatment with 17 beta-estradiol reduced the dyskinetic effect without altering the therapeutic response to L-DOPA, while 17 alpha-estradiol did not alter the dyskinetic and the antiparkinsonian effect.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1542429     DOI: 10.1016/0304-3940(92)90152-w

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

Review 2.  Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.

Authors:  Dean Dluzen; Martin Horstink
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

3.  Oxidative stress and 17-alpha- and 17-beta-estradiol modulate neurofilaments differently.

Authors:  Keith Chiasson; Vicky Lahaie-Collins; Julie Bournival; Benoit Delapierre; Sylvie Gélinas; Maria-Grazia Martinoli
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 4.  Dyskinesias and levodopa therapy: why wait?

Authors:  Michele Matarazzo; Alexandra Perez-Soriano; A Jon Stoessl
Journal:  J Neural Transm (Vienna)       Date:  2018-02-10       Impact factor: 3.575

Review 5.  Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.

Authors:  Darrell W Brann; Krishnan Dhandapani; Chandramohan Wakade; Virendra B Mahesh; Mohammad M Khan
Journal:  Steroids       Date:  2007-02-21       Impact factor: 2.668

6.  Effect of Chronic Methylphenidate Treatment in a Female Experimental Model of Parkinsonism.

Authors:  Hannah V Oakes; David McWethy; Shannon Ketchem; Lily Tran; Kaitlyn Phillips; Laura Oakley; Richard J Smeyne; Brooks B Pond
Journal:  Neurotox Res       Date:  2021-03-05       Impact factor: 3.911

7.  Modulation by Estradiol of L-Dopa-Induced Dyskinesia in a Rat Model of Post-Menopausal Hemiparkinsonism.

Authors:  Kaja Kolmančič; Marko Živin; Maja Zorović
Journal:  Life (Basel)       Date:  2022-04-26

8.  Estrogen and brain vulnerability.

Authors:  Iñigo Azcoitia; Lydia L Doncarlos; Luis M Garcia-Segura
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911

Review 9.  Sex hormones' regulation of rodent physical activity: a review.

Authors:  J Timothy Lightfoot
Journal:  Int J Biol Sci       Date:  2008-04-29       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.